Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDYLP1 stands for "CDYL pseudogene 1," denoting a pseudogene related to the CDYL gene. Pseudogenes are stretches of DNA that resemble known genes but generally lack coding potential due to mutations, deletions, or other defects; as such, they are not translated into functional proteins. "CDYL" is a chromodomain protein involved in chromatin modification and transcriptional repression, but CDYLP1 itself is non-functional and not a molecular target for therapy or drug development. Occasionally, pseudogenes can have regulatory effects (for example, through RNA-mediated mechanisms), but there is no published evidence that CDYLP1 acts as such. It is therefore not a valid entity for pharmacological intervention or as a biomarker. If the intended query was for CDYL (chromodomain Y-like protein) rather than its pseudogene, that is a protein-coding gene involved in chromatin modification and has biological roles, but CDYLP1 is a non-coding pseudogene and not a receptor, enzyme, or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDYL pseudogene 1 (CDYLP1).